Laurent Fischer's Insider Trades & SAST Disclosures
Laurent Fischer's most recent trade in Adverum Biotechnologies Inc was a trade of 150,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Laurent Fischer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 25,000 | 96,614 (0%) | 0% | 0 | Common Stock | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| ATAI Life Sciences N.V. | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 206,000 | 206,000 | - | - | Stock Option | |
| Mirum Pharmaceuticals Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,779 | 8,779 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 5,703 | 5,703 | - | - | Deferred Stock Units | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, PRESIDENT AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2023 | 315,000 | 315,000 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 15 Mar 2023 | 41,239 | 692,141 (1%) | 0% | 0.8 | 32,232 | Common Stock |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 930,000 | 930,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, President and Director | Sale of securities on an exchange or to another person at price $ 1.07 per share. | 19 Sep 2022 | 41,082 | 727,380 (1%) | 0% | 1.1 | 43,941 | Common Stock |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 675,022 | 675,022 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 584,978 | 584,978 | - | - | Performance Based Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, President and Director | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 20 Apr 2022 | 25,000 | 762,462 (1%) | 0% | 1.1 | 27,800 | Common Stock |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 630,000 | 630,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 680,000 | 706,292 (1%) | 1% | 0 | Common Stock | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 455,000 | 455,000 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 17,000 | 17,000 | - | - | Stock Option (right to buy) | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 9.88 per share. | 24 Mar 2021 | 10,000 | 26,292 (0%) | 0% | 9.9 | 98,780 | Common Stock |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 680,000 | 680,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 11.53 per share. | 15 Jan 2021 | 8,600 | 16,292 (0%) | 0% | 11.5 | 99,191 | Common Stock |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO and Director | Purchase of securities on an exchange or from another person at price $ 13.00 per share. | 17 Aug 2020 | 7,692 | 7,692 (0%) | 0% | 13 | 99,996 | Common Stock |
| Adverum Biotechnologies Inc | Laurent Fischer | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 1,200,000 | 1,200,000 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Laurent Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 17,000 | 17,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges